Cargando…

Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells

Liver fibrosis, a common outcome of chronic liver disease characterized by excessive accumulation of extracellular matrix (ECM), is a leading cause of mortality worldwide. The tyrosine kinase inhibitor neratinib is a human epidermal growth factor receptor 2 (HER2) inhibitor approved by the FDA for H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Yong Joo, An, Hyoung-Tae, Park, Jong-Sung, Park, Ogyi, Duh, Alexander J., Kim, Kwangmeyung, Chung, Kyu Hyuck, Lee, Kang Choon, Oh, Yumin, Lee, Seulki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479613/ https://www.ncbi.nlm.nih.gov/pubmed/32901093 http://dx.doi.org/10.1038/s41598-020-71688-2

Ejemplares similares

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
por: Park, Jong-Sung, et al.
Publicado: (2019)

Raman Microspectroscopic Evidence for the Metabolism of a Tyrosine Kinase Inhibitor, Neratinib, in Cancer Cells
por: Aljakouch, Karim, et al.
Publicado: (2018)

Upregulation of receptor tyrosine kinase-like orphan receptor 2 in idiopathic pulmonary fibrosis
por: Son, Ji-Hye, et al.
Publicado: (2021)

HM71224, a selective Bruton’s tyrosine kinase inhibitor, attenuates the development of murine lupus
por: Kim, Yu-Yon, et al.
Publicado: (2017)

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis
por: Son, Mi Kwon, et al.
Publicado: (2013)

Neratinib for breast cancer
Publicado: (2019)

Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis
por: Kim, Jonghwa, et al.
Publicado: (2020)

Analysis of Gut Microbiome Using Explainable Machine Learning Predicts Risk of Diarrhea Associated With Tyrosine Kinase Inhibitor Neratinib: A Pilot Study
por: Wong, Chi Wah, et al.
Publicado: (2021)

Apamin suppresses biliary fibrosis and activation of hepatic stellate cells
por: Kim, Jung-Yeon, et al.
Publicado: (2017)

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells
por: Mimche, Patrice N., et al.
Publicado: (2018)

Protease Activity: Meeting Its Theranostic Potential
por: Lee, Seulki, et al.
Publicado: (2012)

Dendropanoxide, a Triterpenoid from Dendropanax morbifera, Ameliorates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells through Autophagy Inhibition
por: Park, Yong-Joo, et al.
Publicado: (2021)

Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway
por: Seo, Hye-Young, et al.
Publicado: (2019)

Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connective Tissue Growth Factor
por: Seo, Hye-Young, et al.
Publicado: (2020)

The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
por: Booth, Laurence, et al.
Publicado: (2019)

Neratinib protects pancreatic beta cells in diabetes
por: Ardestani, Amin, et al.
Publicado: (2019)

Phosphorylation in Novel Mitochondrial Creatine Kinase Tyrosine Residues Render Cardioprotection against Hypoxia/Reoxygenation Injury
por: Park, Nammi, et al.
Publicado: (2021)

Transcriptome analysis of neratinib treated HER2 positive cancer model vs untreated cancer unravels the molecular mechanism of action of neratinib
por: Alkhezayem, Sara, et al.
Publicado: (2020)

Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as Mer and Axl tyrosine kinase inhibitors
por: Chung, Shin Hyuck, et al.
Publicado: (2020)

Profile of neratinib and its potential in the treatment of breast cancer
por: Feldinger, Katharina, et al.
Publicado: (2015)

Neratinib-Induced Duodenal Ulcer: A Case Report
por: Moftakhar, Bahar, et al.
Publicado: (2020)

Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling
por: Song, Yu, et al.
Publicado: (2023)

Suaeda glauca Attenuates Liver Fibrosis in Mice by Inhibiting TGFβ1-Smad2/3 Signaling in Hepatic Stellate Cells
por: Hong, You-Jung, et al.
Publicado: (2023)

SNS-032 attenuates liver fibrosis by anti-active hepatic stellate cells via inhibition of cyclin dependent kinase 9
por: He, Xiao-Li, et al.
Publicado: (2022)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Hepatic stellate cell–specific knockout of transcriptional intermediary factor 1γ aggravates liver fibrosis
por: Lee, Eun Ju, et al.
Publicado: (2020)

A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
por: Seo, Hyang-Hee, et al.
Publicado: (2017)

Inhibition of Renal Stellate Cell Activation Reduces Renal Fibrosis
por: Cha, Jin Joo, et al.
Publicado: (2020)

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
por: Zhao, Xue-Ke, et al.
Publicado: (2017)

Network approach of the conformational change of c-Src, a tyrosine kinase, by molecular dynamics simulation
por: Yoon, Hyun Jung, et al.
Publicado: (2018)

Inhibition of Tyrosine Kinase Receptor Tie2 Reverts HCV-Induced Hepatic Stellate Cell Activation
por: Martín-Vílchez, Samuel, et al.
Publicado: (2014)

Neratinib for HER2-positive breast cancer with an overlooked option
por: Guo, Liting, et al.
Publicado: (2023)

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells
por: Zhang, Feng, et al.
Publicado: (2014)

Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice
por: Thi Thanh Hai, Nguyen, et al.
Publicado: (2018)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells
por: Xuan, Yuanyuan, et al.
Publicado: (2022)

Retinol from hepatic stellate cells via STRA6 induces lipogenesis on hepatocytes during fibrosis
por: Hwang, Injoo, et al.
Publicado: (2021)

Phloretin Ameliorates Succinate-Induced Liver Fibrosis by Regulating Hepatic Stellate Cells
por: Le, Cong Thuc, et al.
Publicado: (2023)

Cross-Talk between Wnt Signaling and Src Tyrosine Kinase
por: Min, Jung Ki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_06arolpsvec9u5mo7h6cr9umuq